Teleflex announced today that Chair, President and CEO Liam Kelly is departing the company, effective immediately.

In early January 2026, Teleflex announced the past departure of Chairman, President and CEO Liam Kelly, appointed long-time ...

The Teleflex veteran has left the company without a permanent successor. Teleflex has made Stuart Randle, a board member, ...

Teleflex said the decision to move on from Kelly, who had been CEO since January 2018 and chairman since May 2022, is part of its shift to a more focused, higher-growth organization with the planned ...

Stuart Randle Appointed Interim President and CEOBoard Initiates Search for Permanent CEODr. Stephen Klasko Appointed Chairman of the ...

Teleflex shares fell after the medical technology company said it was parting ways with its chief executive officer, and cut its outlook for the year. The stock was down 13% to $110.36 in late morning ...

With this transaction, Intersurgical will integrate the Acute Care and Interventional Urology product ranges, technical expertise, and operations, enabling the Company to deliver a broader, more ...

Teleflex announced a major leadership transition effective January 7–8, 2026, with long-time Chairman, President and CEO Liam Kelly departing and board member Stuart Randle, a veteran medical device ...

Medical technology company Teleflex (NYSE:TFX) will be reporting earnings this Thursday before market hours. Here’s what to look for. Teleflex met analysts’ revenue expectations last quarter, ...

Ratings for Teleflex (NYSE:TFX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...